Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INDURG TRIAL: A Randomized Controlled Trial Using Indocyanine Green During Cholecystectomy in Acute Cholecystitis

NCT05709548 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT05709548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05709548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INDURG TRIAL: A Randomized Controlled Trial Using Indocyanine Green During Cholecystectomy in Acute Cholecystitis
Lead sponsor
Corporacion Parc Tauli
Phase
Phase 4
Overall status
Unknown status
Start date
March 15, 2023
Completion date
December 31, 2025
Enrollment
440 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute cholecystitis, bile duct injury